About the Workshop
Organizers
Dr. Ghada Zamzmi
FDA, USA
FDA, USA
Dr. Ravi Samala
FDA, USA
FDA, USA
Dr. Mariia Sidulova
Medtronic, USA
Medtronic, USA
Dr. Thijs Kooi
Lunit Inc, South Korea
Lunit Inc, South Korea
Dr. Xiaoxiao Li
UBC, Canada
UBC, Canada
Dr. Annika Reinke
DKFZ, Germany
DKFZ, Germany
Advisory Board
Dr. Aldo Badano
FDA, USA
FDA, USA
Dr. Jana Delfino
FDA, USA
FDA, USA
Dr. Ehsan Adeli
Stanford, USA
Stanford, USA
Dr. Marzyeh Ghassemi
MIT, USA
MIT, USA
Dr. Lena Maier-Hein
Heidelberg University, Germany
Heidelberg University, Germany
Dr. Federica Zanca
EFOMP, Belgium
EFOMP, Belgium
Why this Workshop?
The accelerating pace of technological advancements in AI, primarily centered on evolving network architectures, is outpacing the development of corresponding evaluation and regulation frameworks. This disconnect creates a widening gap that not only hinders the effective integration of AI technologies into healthcare but also raises significant concerns about patient safety. Without robust evaluation and regulatory frameworks, AI models may fail to meet the stringent reliability and usability standards required for clinical deployment.While many workshops at MICCAI have explored important themes such as technical developments, ethics, and explainability, there is a noticeable gap in addressing challenges related to evaluation, deployment, and regulation. These challenges, if unaddressed, can significantly impact patient safety and outcomes.